Newsroom | 60647 results

DUBLIN--(BUSINESS WIRE)--The "Advanced Wound Care Management Market in India (2025-2030)" report has been added to ResearchAndMarkets.com's offering. The advanced wound care market in India comprises medical products and technologies designed to manage and treat complex wounds that require more than traditional care. In FY 2024, the advanced wound care management market in India was valued at INR 22.16 Bn and is expected to reach INR 30.79 Bn by FY 2030, expanding at a compound annual growth ra...

MONTREAL--(BUSINESS WIRE)--Pathway today announced that its proprietary large-language model (LLM) scored 96% on a validated set of United States Medical Licensing Examination (USMLE) questions, the highest accuracy yet reported for a specialized medical AI. The result strengthens Pathway’s position as a leading evidence-based decision-support tool for frontline clinicians. In head-to-head testing, Pathway’s “Deep” AI model surpassed domain-specific peers MediSearch Pro, OpenEvidence and Hippoc...

NEW YORK--(BUSINESS WIRE)--Estée Lauder announces an exclusive partnership with Hacienda AltaGracia, Auberge Resorts Collection in Costa Rica, debuting its first Skin Longevity Institute in the Americas within the resort’s world-renowned Casa de Agua Spa. Located adjacent to one of the world’s five “Blue Zones,” regions recognized for their high concentration of centenarians, Hacienda AltaGracia offers a transformative journey grounded in trusted longevity practices. The experience-led programm...

CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) today announced an intended expansion of its radiation oncology portfolio as well as the introduction of the new AI-enabled MR Contour DL™ at the European Society for Therapeutic Radiology and Oncology (ESTRO) 2025 Congress in Vienna, Austria. The company will also showcase its updated Intelligent Radiation Therapy (iRT), a software solution that standardizes complex workflows, helping to enable a shorter timeline from diagnosis to treatmen...

LOS ANGELES--(BUSINESS WIRE)--Turn Therapeutics, a clinical-stage pharmaceutical and medical device company, announced today that it has achieved a critical milestone in its effort to reduce dependency on cold-storage for vaccines. In partnership with the nonprofit International AIDS Vaccine Initiative, Turn Therapeutics has validated a standardized assay and demonstrated 100% recovery of vesicular stomatitis virus (VSV) -- a widely used viral backbone in vaccine development -- after both 24 an...

RALEIGH, N.C.--(BUSINESS WIRE)--Gemelli Biotech's Trio-Smart® 3-Gas Breath Test Featured at DDW 2025....

WILMINGTON, Del.--(BUSINESS WIRE)--Positive high-level results from the Phase III KALOS and LOGOS trials in patients with uncontrolled asthma showed that AstraZeneca’s fixed-dose triple-combination therapy BREZTRI AEROSPHERE (budesonide/glycopyrronium/formoterol fumarate or BGF (320/28.8/9.6μg)) met all primary endpoints, demonstrating a statistically significant and clinically meaningful improvement in lung function compared with dual-combination inhaled corticosteroid/long-acting beta2-agonis...

フィラデルフィア--(BUSINESS WIRE)--（ビジネスワイヤ） -- PCIファーマ・サービシズ（以下「PCI」）は、革新的なバイオ医薬品治療に特化した世界有数の開発・製造受託機関（CDMO）である味の素アルテア（以下「アルテア」）の買収を完了しました。アルテアは、米国を拠点とする無菌充填製剤CDMOであり、日本の味の素株式会社の子会社です。今回の買収は、米国と欧州における施設を対象とした複数年にわたる投資戦略の礎となるものです。米国では、アルテアの資産がPCIの既存の無菌充填および高度な薬物送達オペレーションと統合され、サンディエゴにプレフィルド・シリンジおよびカートリッジ用の最新鋭の大規模無菌設備を備えた世界クラスの大規模製造拠点が形成されます。アルテアのキャンパスは、カスタマイズ可能でスケーラブルなオリゴヌクレオチドおよびペプチドの製造に特化しており、ナノ粒子、mRNA、MAB、タンパク質、その他の生物製剤を含む広範な注射剤のための複雑な製剤と凍結乾燥のPCI社の既存製造をサポートします。 この買収に関する追加情報は、PCIのウェブサイトの専用ウェブページでご覧いただ...

費城--(BUSINESS WIRE)--(美國商業資訊)-- PCI Pharma Services (“PCI”)是一家專注于創新生物製藥療法的全球領先委託研發生產組織(CDMO)。目前該公司已完成對美國無菌灌裝CDMO、日本Ajinomoto Co., Inc.的子公司Ajinomoto Althea, Inc. (“Althea”)的收購。此次收購是PCI在美國和歐洲工廠多年投資策略的關鍵一環。在美國，Althea的資產將與PCI的現有無菌灌裝和先進給藥系統業務相整合，在聖地牙哥打造世界一流的大規模生產基地，配備最先進的大規模無菌灌裝廠，專門生產預充式注射器和藥筒。在其他類別中，Althea園區還特別擅長客製化、可擴充的寡核苷酸和胜肽類生產，這將增強PCI在複雜製劑和凍幹製程方面的現有生產能力，涵蓋奈米顆粒、mRNA、單克隆抗體、蛋白質及其他生物製劑等多種注射劑型。 有關此次收購的更多資訊，請造訪PCI網站的專用網頁。 此次收購還新增了高活性西林瓶灌裝與凍幹能力，不僅擴大了PCI的無菌灌裝產能，更使其高效切入快速崛起的腫瘤治療領域——高活性抗體偶聯藥物(ADC)的生產。事實上，...

MADISON, Wis.--(BUSINESS WIRE)--Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic tests, today announced that company management will participate in the following conference and invited investors to participate by webcast. BofA Securities Health Care Conference, Las Vegas Fireside chat on Wednesday, May 14, 2025 at 1:40 p.m. ET (10:40 a.m. PT) The webcast can be accessed in the investor relations section of Exact Sciences’ website at www.exactsciences.co...